You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAS102

Showing 1 - 25 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Recruiting
  • Gastric Cancer
  • Fruquintinib, TAS102
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

TAS-102 in Combination With Regorafenib or Fruquintinib for

Not yet recruiting
  • TAS 102
  • +3 more
  • (no location specified)
Aug 7, 2023

Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Tas-102(Suyuan) combined with bevacizumab
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Oct 14, 2023

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 24, 2023

Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

Completed
  • Rectal Adenocarcinoma
  • +4 more
  • Quality-of-Life Assessment
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jan 3, 2023

Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Not yet recruiting
  • Colon Cancer
  • Rectal Cancer
  • TAS-102, oxaliplatin, irinotecan with bevacizumab
  • Elizabeth, New Jersey
  • +6 more
Apr 7, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (fruquintinib plus TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus TAS-102
  • Guangzhou, Guangdong, China
    the first affiliated hospital of Sun Yat-sen University
Aug 17, 2022

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick

Recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Elizabeth, New Jersey
  • +5 more
Oct 17, 2022

Pancreatic Tumors Trial in Guangzhou (Surufatinib, TAS-102)

Not yet recruiting
  • Pancreatic Neoplasms
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Jul 28, 2022

Immunotherapy, Colorectal Cancer Trial in Fuzhou (Tislelizumab, bevacizumab, TAS-102)

Recruiting
  • Immunotherapy
  • Colorectal Cancer
  • Fuzhou, Fujian, China
  • +1 more
Jul 20, 2022

Colorectal Cancer Trial in Houston (TAS-102)

Recruiting
  • Colorectal Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Jun 7, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Bevacizumab combined with Oxaliplatin and TAS-102
  • (no location specified)
May 16, 2022

Pancreas Cancer Trial in Hong Kong (TAS 102)

Recruiting
  • Pancreas Cancer
  • TAS 102
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, HKU
Jul 13, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Bladder Cancer Trial in Fairway, Kansas City (TAS 102)

Recruiting
  • Bladder Cancer
  • TAS 102
  • Fairway, Kansas
  • +1 more
Mar 9, 2022

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)

Active, not recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
  • +1 more
Apr 4, 2022